Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro
Journal of Natural Medicines · 2025
DOI: 10.1007/s11418-024-01855-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Medicines, 2025. Verfasst von Hinako Koze und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science and Engineering, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan. Hauptthemen laut MEDLINE: SARS-CoV-2, Virus Replication, Antiviral Agents, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kagoshima University.
Abstract (Originalsprache)
The persistence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the emergence of new mutant strains continue to present a substantial threat with potential for future pandemics. Safe, effective, and readily available COVID-19 therapeutics are urgently needed to prepare for future coronavirus pandemics. To help identify new antiviral agents, the present study focused on natural products in the extracts of Holy Basil, Ocimum tenuiflorum L., which show potential inhibitory effects against the SARS-CoV-2 main protease (M pro ). Bioassay-guided isolation of the MeOH extracts of O. tenuiflorum led to the identification of a sulfur-containing glyceroglycolipid, sulfoquinovosyl diacylglycerol (SQDG: 1 ), as a potent M pro inhibitor that effectively inhibited M pro activity (IC 50 : 0.42 µM). SQDG ( 1 ) also markedly suppressed SARS-CoV-2 replication (EC 50 , 51.2 µM) in vitro while displaying no cytotoxicity (CC 50 > 100 µM). Further inhibition kinetic studies and docking simulations clearly demonstrated that SQDG strongly inhibited SARS-CoV-2 M pro in a competitive and mixed-inhibition manner. These findings highlight SQDG as a promising lead compound for COVID-19 therapy and emphasize the need to explore new drugs from natural sources. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Graduate School of Science and Engineering, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan.
- Faculty of Science, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan.
- Department of Translational Research, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan.
- Department of Chemistry, Biotechnology, and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima, 890-0065, Japan.
- Institute for Materials Chemistry and Engineering, Kyushu University, 744 Motooka Nishi-ku, Fukuoka, 819-0395, Japan.
- Drug Discovery Structural Biology Platform Unit, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa, 230-0045, Japan.
Förderung
- Kagoshima University
Zitieren
APA
Koze, H., Sudoh, M., Onitsuka, S., Okamura, H., Ishikawa, T., Tani, F., Miyata-Yabuki, Y., Shirouzu, M., Baba, M., Okamoto, M., & Hamada, T. (2025). Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01855-6
Vancouver
Koze H, Sudoh M, Onitsuka S, Okamura H, Ishikawa T, Tani F, et al. Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro. Journal of Natural Medicines. 2025. doi:10.1007/s11418-024-01855-6
BibTeX
@article{Koze2025,
author = {Koze, Hinako and Sudoh, Masayuki and Onitsuka, Satoaki and Okamura, Hiroaki and Ishikawa, Takeshi and Tani, Fumito and Miyata-Yabuki, Yukako and Shirouzu, Mikako and Baba, Masanori and Okamoto, Mika and Hamada, Toshiyuki},
title = {Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro},
journal = {Journal of Natural Medicines},
year = {2025},
doi = {10.1007/s11418-024-01855-6}
}
EUVIMED